AANP Member Spotlight: Kathleen Brioglio

NIDA Grant Recipient

Kathleen Broglio rev
Kathleen Broglio, DNP, ANP-BC, ACHPN, CPE, FPCN
Palliative Medicine, Dartmouth-Hitchcock Medical Center

Hear from AANP member Kathleen Brioglio, DNP, ANP-BC, ACHPN, CPE, FPCN, on her experience as a recipient of the 2018 NIDA Mentored Training Award in Substance Use Disorder Treatment Science.

Q: What led to you applying for the NIDA award?
A: I specialize in pain and palliative medicine, but I was becoming more interested in Opioid Use Disorder (OUD) and was starting to perform research in that field. After I was a speaker at a specialty conference, I was introduced to Diane Padden at AANP and found out about the NIDA grant. As a member of AANP, this was right down my alley because I had already started exploring what to do with patients who have Substance Use Disorder (SUD) along with serious illness—a population that had been ignored in existing guidelines.

Q: How did you find your mentor?
A: I moved to Dartmouth-Hitchcock Medical Center in 2016, but I had already developed a networking relationship with Dr. Seddon Savage, advisor to Dartmouth-Hitchcock’s Substance Abuse and Mental Health Initiative and professor of medicine at the Geisel School of Medicine at Dartmouth. Our paths had crossed throughout our careers because we’ve been on different panels nationally and had been speakers at regional conferences. She started pulling me into meetings about substance abuse, and when this grant became a possibility, I asked if she’d be willing to mentor as an expert in pain management. 

Q: What was the most rewarding part of your experience?
A: I was already well established in my NP career, but the NIDA award provided the jumpstart I needed to help me gain more expertise within the addiction field and provided seed time for new projects. I previously got waived in buprenorphine prescribing and received support to start a small medication-assisted therapy (MAT) pilot clinic within palliative care. I’m using the NIDA grant to survey whether providers in oncology screen patients for SUD and to provide follow-up education with a post-survey. Through the initial survey, I found that while patients may be at moderate or high risk for SUD, there is a need for and an opportunity to increase our screening. In addition, I’ll be presenting nationally next year, and two of our providers both got waivered in buprenorphine, which can make a tangible difference in the lives of our patients. 

Q: What advice would you give to future applicants?
A: I think it’s important to develop relationships—outside and within your workplace. The purpose of the award is to use it as a seed to expand your work, so you need to know what’s out there. Look within your community to see who is doing addiction medicine, to see what services exist and to find what you’re interested in. It’s absolutely important to have an idea of what you want to do and to make sure you have a network to help your project be the most successful it can be.

Q: How has this experience impacted you?
A: I’ve really appreciated AANP’s support in helping me make connections at NIDA. AANP has really taken the lead in making sure NPs are educated in all specialties. Considering that an estimated 72,000 people died last year of overdose, this field is something all NPs are going to be touched by. This NIDA grant offers valuable feedback from mentors and gets people excited to apply and expand their knowledge of SUD and OUD treatment.

Do you have an idea for a project that will improve the dissemination or adoption of existing SUD treatment research? Are you looking for the chance to work alongside a mentor to increase your clinical knowledge of SUD treatment?

Apply for the NIDA Mentored Training Award in Substance Use Disorder Treatment Science!

Applications are due no later than October 17, 2018. Up to two grants will be awarded this funding cycle (January–December 2019). Recipients will be notified by December 7, 2018.